Core Laboratories
CLB
360 hedge funds and large institutions have $4.97B invested in Core Laboratories in 2017 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 136 increasing their positions, 119 reducing their positions, and 36 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 119
11% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 36
3.54% more ownership
Funds ownership: 107.48% → 111.02% (+3.5%)
0% more funds holding
Funds holding: 360 → 360 (0)
9% less capital invested
Capital invested by funds: $5.48B → $4.97B (-$516M)
34% less call options, than puts
Call options by funds: $13.7M | Put options by funds: $20.6M
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$80.5M |
| 2 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$68.2M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$53.9M |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$32.7M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$30.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$54.4M |
| 2 |
WP
Wedgewood Partners
St Louis,
Missouri
|
-$33.8M |
| 3 |
RA
RiverPark Advisors
New York
|
-$29.9M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$15.4M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$15M |
CLB Hedge Fund Activity: Q2 2017 in Review
360 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2017, worth a combined $4.97B — down 9.4% from $5.48B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new CLB positions and 36 closed out — a net gain of 4 holders — while 136 added to existing stakes and 119 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $80.5M. The largest seller was Royal Bank of Canada, cutting an estimated $54.4M.
- 360 institutional investors held Core Laboratories (CLB) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $4.97B of Core Laboratories stock for Q2 2017, down 9.4% quarter-over-quarter.
- 40 funds opened new Core Laboratories positions in Q2 2017 and 36 closed out, a net change of +4 holders.
- The largest Core Laboratories buyer in Q2 2017 was Millennium Management, an estimated $80.5M added.
- The largest Core Laboratories seller in Q2 2017 was Royal Bank of Canada, an estimated $54.4M sold.
Based on aggregated 13F filings for Q2 2017.